What Have We Learned From the Calcium Channel Blocker Controversy?
Open Access
- 28 April 1998
- journal article
- editorial
- Published by Wolters Kluwer Health in Circulation
- Vol. 97 (16) , 1529-1531
- https://doi.org/10.1161/01.cir.97.16.1529
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Valvular Heart Disease Associated with Fenfluramine–PhentermineNew England Journal of Medicine, 1997
- Large-scale randomized evidence: Large, simple trials and overviews of trialsJournal of Clinical Epidemiology, 1995
- Calcium antagonists in the treatment of ischemic heart diseaseCoronary Artery Disease, 1994
- Role of coronary vasospasm in the pathogenesis of myocardial infarction: Study in patients with no significant coronary stenosisAmerican Heart Journal, 1993
- Publication Bias: The Problem That Won't Go AwayAnnals of the New York Academy of Sciences, 1993
- The Antiarrhythmic and Antifibrillatory Effects of Calcium AntagonistsJournal of Cardiovascular Pharmacology, 1991
- Calcium channel blockers in acute myocardial infarction and unstable angina: an overview.BMJ, 1989
- Calcium antagonists in hypertensionThe American Journal of Medicine, 1989
- The Effect of Diltiazem on Mortality and Reinfarction after Myocardial InfarctionNew England Journal of Medicine, 1988
- RANDOMISED TRIAL OF INTRAVENOUS ATENOLOL AMONG 16 027 CASES OF SUSPECTED ACUTE MYOCARDIAL INFARCTION: ISIS-1The Lancet, 1986